Key facts
- This page summarizes Erica L. Monaco's Form 4 filing for Biofrontera Inc. (BFRI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 May 2023, 21:03.
Erica L. Monaco - 18 May 2023 Form 4 Insider Report for Biofrontera Inc. (BFRI)
- Reporting relationship
- Chief Executive Officer
- Issuer ticker
- BFRI
- Reported as of
- 18 May 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 May 2023, 21:03:05 UTC
- Prior SEC filing
- 19 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel Hakansson, Attorney-in-fact for Erica L Monaco
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Erica L. Monaco filed Form 4 for Biofrontera Inc. (BFRI) on 22 May 2023.
Change
- Previous filing in this sequence was filed on 19 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BFRI
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +76,336
- Change %
- +135%
- Price
- Shares after
- 133,025
- Date
- 18 May 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BFRI
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -76,336
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 76,336
- Date
- 18 May 2023
- Ownership
- Direct
- Underlying class
- Commom Stock
- Underlying amount
- 76,336
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock units covert into common stock on a one-for-one basis.
Footnote F2
On May 18, 2022, the reporting person was granted 152,672 restricted stock units, vesting in two equal annual installments beginning on May 18,2023.